Dravet Syndrome Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 10
SKU : PH1102
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
loading
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
Request new version
FAQ’s
What is the Projected CAGR value of the Dravet Syndrome Therapeutics Market ?
Dravet Syndrome Therapeutics Market is expected to grow at a CAGR of 11.5% during the forecast period 2024-2031.
Who are the key players in Dravet Syndrome Therapeutics Market ?
Major players are Epygenix Therapeutics, Inc., GW Pharmaceuticals Plc., Ovid Therapeutics, Takeda Pharmaceutical Company Ltd, OPKO Health Inc., Zogenix, Inc, Biocodex S.A., PTC Therapeutics, Inc., and Biscayne Neurotherapeutics, Inc.
Related Reports
pharmaceuticals

Dry Eye Syndrome Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 11
Starting from

$4350

pharmaceuticals

Morquio Syndrome Therapy Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2023 November 06
Starting from

$4350

pharmaceuticals

Marfan Syndrome Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 June 13
Starting from

$4350